| Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine Fibroid (NCT05448365) | Lo.Li.Pharma s.r.l | 2022-07-01 |
| Effect of Addition of Steroids on Duration of Analgesia (NCT04126824) | University of California, Los Angeles | 2022-01-06 |
| A Study to Assess Patient-Reported Quality of Life and Effectiveness on Control of Bleeding in Adult Participants With Heavy Menstrual Bleeding Due to Uterine Fibroids Taking Oral Oriahnn Capsules (NCT05026502) | AbbVie | 2021-10-05 |
| Evaluation of a Hysteroscopic Method With Vaporization in the Hysteroscopic Treatment of Submucosal Uterine Fibroids (NCT05078307) | Assistance Publique Hopitaux De Marseille | 2021-09-25 |
| Pharmacokinetics and Hepatic Safety of EGCG (NCT04177693) | Yale University | 2020-11-24 |
| A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Patients in Canada (NCT04567095) | Allergan | 2020-10-31 |
| A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Healthcare Professionals in Canada (NCT04567589) | Allergan | 2020-09-30 |
| Phase III Study of MR-Guided Focused Ultrasound Surgery for the Treatment of Uterine Fibroids Compared to Myomectomy (NCT03948789) | Krankenhaus Nordwest | 2020-07-15 |
| A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (NCT03886220) | AbbVie | 2019-04-12 |
| Assessment of Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (NCT03699176) | Bayer | 2018-10-27 |
| Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids (NCT03751124) | Myovant Sciences GmbH | 2018-10-16 |
| Association Between Vitamin D and the Risk of Uterine Fibroids (NCT03586947) | Second Affiliated Hospital of Wenzhou Medical University | 2018-09-15 |
| Pharmacokinetics and Safety of Vilaprisan in Renal Impairment (NCT03411980) | Bayer | 2018-02-02 |
| Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4) (NCT03400956) | Bayer | 2018-01-24 |
| Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3) (NCT03400943) | Bayer | 2018-01-17 |
| Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis (NCT03500367) | Peking Union Medical College Hospital | 2018-01-01 |
| Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (NCT03271489) | AbbVie | 2017-09-13 |
| A Study to Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (NCT03240523) | Bayer | 2017-07-31 |
| Evaluation of Uterine Patency Following Sonography-guided Transcervical Ablation of Fibroids (NCT02844920) | Gynesonics | 2017-07-20 |
| Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (NCT03194646) | Bayer | 2017-06-30 |
| Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids (NCT03070951) | ObsEva SA | 2017-05-23 |
| Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids (NCT03070899) | ObsEva SA | 2017-04-20 |
| Tailored Radiofrequency Ablation of Uterine Myomas (NCT04091529) | International Evangelical Hospital | 2017-03-01 |
| Study of Volume Reduction of Uterine Fibroids After Embolization or Microwave Treatment (NCT02942537) | Karolinska Institutet | 2017-01-23 |
| Safety and Efficacy of Embozene Microspheres for Uterine Fibroid Embolization (NCT02884960) | Gary Siskin, MD | 2016-10-01 |
| An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids (NCT02925494) | AbbVie | 2016-09-14 |
| An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids (NCT02811159) | Repros Therapeutics Inc. | 2016-07-26 |
| Point of Care 3D Ultrasound for Various Applications: A Pilot Study (NCT02831556) | Duke University | 2016-07-01 |
| Endometrial Preparation Before Operative Hysteroscopy in Premenopausal Women (NCT02440750) | University of Cagliari | 2016-06-01 |
| A Placebo-Controlled, Phase 3 Study of Relugolix (TAK-385) 40 mg in the Treatment of Pain Symptoms Associated With Uterine Fibroids (NCT02655224) | Takeda | 2016-03-26 |
| A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids (NCT02655237) | Takeda | 2016-03-05 |
| Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study) (NCT02691494) | AbbVie | 2016-02-03 |
| Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU) (NCT02914704) | Turku University Hospital | 2016-01-01 |
| Non-interventional Study to Evaluate Long Term Safety, Prescription Management Patterns of Esmya in a Long Term Setting (NCT02748460) | PregLem SA | 2015-12-22 |
| Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (NCT02654054) | AbbVie | 2015-12-22 |
| PerClot Compared to Usual Care in Gynaecology Procedures (NCT02835391) | CryoLife Europa | 2015-11-01 |
| Ulipristal Acetate 10 mg and Asisted Reproduction (NCT02425878) | Instituto Valenciano de Infertilidad, IVI VALENCIA | 2015-10-19 |
| Optimal Order of Concurrent Office Hysteroscopy and Endometrial Biopsy (NCT02472184) | University of South Florida | 2015-10-01 |
| Pilot of Letrozole for Uterine Myomas (NCT02470741) | University of California, San Francisco | 2015-07-01 |
| A Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids (NCT02301897) | Repros Therapeutics Inc. | 2015-03-16 |
| Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine Fibroids (NCT02323646) | Repros Therapeutics Inc. | 2015-02-12 |
| Predictive Factors for Complete Myoma Resection During Hysteroscopic Myomectomy (NCT04400942) | Ospedale Policlinico San Martino | 2015-01-01 |
| Comparing Patient-Centered Outcomes After Treatment for Uterine Fibroids (NCT02819609) | Quintiles, Inc. | 2014-11-01 |
| Clinical Test of the MRgHIFU System on Uterine Fibroids (NCT02283502) | Chin-Jung Wang | 2014-09-01 |
| Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry (NCT02100904) | University of California, San Francisco | 2014-05-01 |
| AMH Levels Change During Treatment With GnRh Agonist (NCT02086279) | University Magna Graecia | 2014-03-01 |
| Prophylactic Salpingectomy for the Prevention of the Ovarian Cancer: Comparison Between Surgical Techniques (NCT02086370) | University Magna Graecia | 2014-03-01 |
| Ovarian Reserve Modification After Lps Hysterectomy With Bilateral Salpingectomy (NCT02086344) | University Magna Graecia | 2014-02-01 |
| Vaginal vs. Laparoscopic Hysterectomy (NCT02059954) | Medical University of Graz | 2014-01-01 |
| What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography (NCT01992718) | University of Michigan | 2013-11-01 |
| Does 3D Laparoscopy Improve Vaginal Cuff Suture Time? (NCT02192606) | Brigham and Women's Hospital | 2013-11-01 |
| Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF) (NCT01817530) | AbbVie | 2013-04-08 |
| Post Market Evaluation of Acessa With TAG (NCT01842789) | Acessa Health, Inc. | 2013-04-01 |
| Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation (NCT01998854) | Gynesonics | 2013-02-01 |
| Post Market TRUST Study (NCT01563783) | Acessa Health, Inc. | 2012-12-01 |
| Laparoscopic Uterine Sparing Techniques Outcomes and Reinterventions (NCT01750008) | Acessa Health, Inc. | 2012-11-01 |
| Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Who Have Completed ZPV-200 (NCT01739621) | Repros Therapeutics Inc. | 2012-09-01 |
| Extension of Study ZPV-200 (NCT01631903) | Repros Therapeutics Inc. | 2012-09-01 |
| Embozene Microspheres for Uterine Fibroid Embolization (UFE) (NCT01675011) | Boston Scientific Corporation | 2012-08-01 |
| PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (NCT01642472) | PregLem SA | 2012-07-01 |
| PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (NCT01629563) | PregLem SA | 2012-06-01 |
| Fibroid Ablation Study - Large Fibroids (NCT01539187) | Gynesonics | 2012-06-01 |
| A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine Fibroids (NCT01635452) | PregLem SA | 2012-05-01 |
| China Clinical Trial for Therapeutic MR-HIFU Ablation of Uterine Fibroids (NCT01588899) | Philips Healthcare | 2012-05-01 |
| Sonalleve Fibroid Ablation Pivotal Clinical Trial for MR-HIFU of Uterine Fibroids (NCT01504308) | Philips Healthcare | 2012-05-01 |
| Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids (NCT01451424) | Repros Therapeutics Inc. | 2012-02-01 |
| Preemptive Analgesia Following Uterine Artery Embolization (NCT01555073) | Northwestern University | 2011-10-01 |
| Efficacy and Safety of TAK-385 in the Treatment of Uterine Fibroids (NCT01452659) | Takeda | 2011-10-01 |
| Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids (NCT01441635) | AbbVie (prior sponsor, Abbott) | 2011-09-08 |
| Study to Evaluate the Safety and Effectiveness of MRgFUS Compared With Myomectomy for the Treatment of Uterine Fibroids (NCT01328067) | InSightec | 2011-06-01 |
| Magnetic Resonance Guided Focused Ultrasound for Uterine Fibroids (NCT01377519) | University of California, San Francisco | 2011-06-01 |
| Fibroid Ablation Study (NCT01226290) | Gynesonics | 2011-01-01 |
| PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII-extension Study) (NCT01252069) | PregLem SA | 2011-01-01 |
| MyoSure Hysteroscopic Tissue Removal System Registry Study (NCT01369758) | Hologic, Inc. | 2010-11-01 |
| Magnetic Resonance Elastography (MRE) of Uterine Fibroids (NCT01229826) | Mayo Clinic | 2010-10-01 |
| PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (NCT01156857) | PregLem SA | 2010-07-01 |
| HOME Study: Hysteroscopic Office Myomectomy Evaluation (NCT01152112) | Hologic, Inc. | 2010-06-01 |
| Safety Study of ExAblate for the Treatment of Uterine Fibroids (NCT01142791) | InSightec | 2010-05-01 |
| The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids. (NCT00995878) | Mayo Clinic | 2010-04-29 |
| A Pilot Study to Determine Optimal Procedure Steps to Obtain and Maintain Uterine Artery Occlusion With the D-UAO Device (NCT01140555) | Ethicon, Inc. | 2010-04-01 |
| Mifepristone to Treat Uterine Fibroids (NCT01786226) | Mediterranea Medica S. L. | 2010-03-01 |
| A Clinical Study to Evaluate Safety of the ExAblate 2100 UF V2 System in the Treatment of Symptomatic Uterine Fibroids (NCT01092988) | InSightec | 2010-03-01 |
| Minimally Invasive Benign Hysterectomy (NCT01865929) | Region Skane | 2010-01-01 |
| Comparative Sedation Study of the MyoSure Hysteroscopic Tissue Removal System (NCT00979342) | Hologic, Inc. | 2009-11-01 |
| Uterine Artery Embolization(UAE) Versus High-Intensity-Focused-Ultrasound(HIFU) for Treatment of Uterine Fibroids (NCT01834703) | Chinese University of Hong Kong | 2009-05-01 |
| Safety of 25 and 50 mg Proellex® in the Treatment of Women With Symptomatic Uterine Fibroids (NCT01069120) | Repros Therapeutics Inc. | 2009-04-01 |
| Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine Fibroids (NCT00874029) | Acessa Health, Inc. | 2009-03-01 |
| Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids (NCT00853567) | Repros Therapeutics Inc. | 2009-02-01 |
| Pilot Study of MRI-Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids (NCT00837161) | Philips Healthcare | 2009-01-01 |
| The Benefits and Limits of Laparoscopic Surgery for Uterine Fibroids (NCT00860002) | Taipei Veterans General Hospital, Taiwan | 2009-01-01 |
| Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids (NCT00737282) | Repros Therapeutics Inc. | 2008-10-01 |
| Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids (NCT00785356) | Repros Therapeutics Inc. | 2008-10-01 |
| Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study (NCT00768742) | Gynesonics | 2008-09-01 |
| Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids (NCT00735553) | Repros Therapeutics Inc. | 2008-08-01 |
| Hysteroscopic Cryomyolysis for the Treatment of Submucosal Leiomyomata (NCT00731341) | Boston Scientific Corporation | 2008-07-01 |
| An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext (NCT00958893) | Repros Therapeutics Inc. | 2008-06-01 |
| Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids (NCT00702702) | Repros Therapeutics Inc. | 2008-06-01 |
| Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids (NCT00683917) | Repros Therapeutics Inc. | 2008-05-01 |
| Mifepristone 10 or 5 mg for 6 Months to Treat Uterine Fibroids (NCT00886873) | Mediterranea Medica S. L. | 2008-05-01 |
| Doppler-Guided Uterine Artery Occlusion (DUAO) Device for Fibroid Related Bleeding (NCT00496080) | Ethicon, Inc. | 2007-06-01 |